🇺🇸 FDA
Patent

US 9474728

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

granted A61KA61K31/135A61K31/137

Quick answer

US patent 9474728 (Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine) held by TONIX PHARMA LIMITED expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/135, A61K31/137, A61K45/06, A61K9/0053